Recurrent Adult Diffuse Small Cleaved Cell Lymphoma Completed Phase 2 Trials for Ondansetron (DB00904)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0028499 (Recurrent Adult Diffuse Small Cleaved Cell Lymphoma) | Completed | 2 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT00795769 | Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell Transplant | Supportive Care |